Skip to main content

Table 2 Use of autologous stem cell transplantation after high dose chemotherapy in different entities of non-Hodgkin´s lymphoma

From: Stem cell transplantation in strategies for curing HIV/AIDS

No. patients

Entity

Results

Reference

20

NHL

85 % progression free survival

[53]

53

NHL, HL

Randomized with HIV-negative group: no significant difference in OS, PFS

[12]

68

NHL, HL

PFS 56 % at median follow up of 32 months

[54]

7

NHL

SCT with anti CD20 antibody

[55]

3

MM

CR

[56]

1

CNS-NHL

CR

[55]